Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Viremia D014766 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Bronchiectasis D001987 7 associated lipids
Anthrax D000881 1 associated lipids
Heart Injuries D006335 6 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kim YD et al. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. 1993 Prostaglandins pmid:8234834
Kojima T et al. Production and secretion of progesterone in vitro and presence of platelet activating factor (PAF) in early pregnancy of the marsupial, Macropus eugenii. 1993 Reprod. Fertil. Dev. pmid:8234890
Nobe K et al. Effect of diacylglycerol kinase inhibitor, R59022 on cytosolic free calcium level and force development in guinea pig taenia coli. 1993 Res. Commun. Chem. Pathol. Pharmacol. pmid:8235067
Krämer K et al. Studies on the metabolism of metallothionein and alkaline phosphatase of adult rat primary hepatocyte cultures: role of fetal calf serum and agonists of the phosphoinositide cascade. 1993 Z Ernahrungswiss pmid:8237077
Ma Y et al. [PAF antagonistic benzofuran neolignans from Piper kadsura]. 1993 Yao Xue Xue Bao pmid:8237383
Weintraub ST et al. Synthesis of pentafluorobenzoic anhydride: a superior derivatizing agent for lipids. 1993 Anal. Chem. pmid:8238933
Fletcher JR Eicosanoids. Critical agents in the physiological process and cellular injury. 1993 Arch Surg pmid:8239981
Laneuville O et al. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4. 1993 Biochem. J. pmid:8240236
Rochon YP and Frojmovic MM Regulation of human neutrophil aggregation: comparable latent times, activator sensitivities, and exponential decay in aggregability for FMLP, platelet-activating factor, and leukotriene B4. 1993 Blood pmid:8241512
Perez SA et al. Eosinophil granulocyte proliferation induced by an intermediate factor generated in the pleural cavity of rats injected with platelet-activating factor-acether. 1993 Int. Arch. Allergy Immunol. pmid:8241799
Saito H et al. Platelet-activating-factor-induced augmentation of production of eosinophil-lineage cells in hematopoietic precursor cells obtained from human umbilical cord blood. 1993 Int. Arch. Allergy Immunol. pmid:8241800
Eda R et al. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. 1993 Int. Arch. Allergy Immunol. pmid:8241801
Bkaily G et al. PAF activation of a voltage-gated R-type Ca2+ channel in human and canine aortic endothelial cells. 1993 Br. J. Pharmacol. pmid:8242226
Hu W et al. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. 1993 Br. J. Pharmacol. pmid:8242237
Emmendörffer A et al. Production of oxygen radicals by fibroblasts and neutrophils from a patient with x-linked chronic granulomatous disease. 1993 Eur. J. Haematol. pmid:8243611
McDonald PP et al. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. 1993 J. Immunol. pmid:8245474
van der Bruggen T et al. Transient exposure of human eosinophils to the protein kinase C inhibitors CGP39-360, CGP41-251, and CGP44-800 leads to priming of the respiratory burst induced by opsonized particles. 1993 J. Leukoc. Biol. pmid:8245706
Duque I et al. Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells. 1993 J. Pharmacol. Exp. Ther. pmid:8246135
Musemeche CA et al. Intestinal ischemia in the newborn: the role of intestinal maturation. 1993 J. Surg. Res. pmid:8246492
Zeng GQ et al. Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture. 1993 Zhongguo Yao Li Xue Bao pmid:8249627
Zhang B and Long K Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro. 1993 Zhongguo Yao Li Xue Bao pmid:8249632
Imai T et al. [Relation of platelet activating factor induced airway hyperresponsiveness to thromboxane A2 and neutrophil in dogs]. 1993 Arerugi pmid:8250720
Archer CB Platelet activating factor--a mediator of inflammation in the skin--medical implications. 1993 Clin. Exp. Dermatol. pmid:8252783
Hotchkiss JA et al. Platelet activating factor stimulates rapid mucin secretion in rat nasal airways in vivo. 1993 Sep-Oct Exp. Lung Res. pmid:8253058
Nathan N and Denziot Y Platelet-activating factor and nonalcoholic cirrhotics. 1993 Gastroenterology pmid:8253376
Sengoku K et al. Effects of platelet activating factor on human sperm function in vitro. 1993 Hum. Reprod. pmid:8253933
Palmblad J et al. Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. 1994 J. Immunol. pmid:8254196
Chopra K et al. Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size. 1993 Methods Find Exp Clin Pharmacol pmid:8255122
Herbert JM et al. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. 1993 J Lipid Mediat pmid:8257776
Squadrito F et al. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. 1993 J Lipid Mediat pmid:8257777
Noris M et al. Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis. 1993 Kidney Int. pmid:8258952
Doly M et al. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. 1993 Ophthalmic Res. pmid:8259265
Steen VM et al. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. 1993 Thromb. Haemost. pmid:8259557
MacKendrick W et al. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. 1993 Biol. Neonate pmid:8260551
Elwood W et al. Role of cyclooxygenase and 5-lipoxygenase metabolites, platelet-activating factor and 5-hydroxytryptamine in allergen-induced airway responses in the brown Norway rat. 1994 Int. Arch. Allergy Immunol. pmid:8260852
Hartnell A et al. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. 1993 Immunology pmid:8262555
Raeburn D and Karlsson JA Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. 1993 J. Pharmacol. Exp. Ther. pmid:8263775
Rabinovici R et al. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. 1993 J. Pharmacol. Exp. Ther. pmid:8263817
McManus LM et al. PAF molecular heterogeneity: pathobiological implications. 1993 Lab. Invest. pmid:8264227
Freire-Maia L and de Matos IM Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. 1993 Toxicon pmid:8266352
Corcoran PC et al. Reduction of conjugated dienes in lung transplantation: effect of BN 52021. 1993 Ann. Thorac. Surg. pmid:8267425
Waga I et al. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin. 1993 Biochem. Biophys. Res. Commun. pmid:8267581
Manzini S et al. Interactions between sensory neuropeptides and lipid mediators in the airways. 1993 J Lipid Mediat pmid:8268456
Tjebbes GW et al. Production of lipid mediators in experimental keratitis of rabbit eye. 1993 J Lipid Mediat pmid:8268458
Vásquez-Bravo YL et al. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists. 1993 J Lipid Mediat pmid:8268459
Okamoto Y et al. PAF-releasing factor in human serum and inflammatory exudate. 1993 J Lipid Mediat pmid:8268461
David S et al. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate. 1993 Jul-Sep ASAIO J. pmid:8268642
Stephens CJ et al. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. 1993 Coron. Artery Dis. pmid:8269210
Hirashima Y et al. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. 1994 J. Neurosurg. pmid:8271019
Roberts C et al. Platelet activating factor (PAF) enhances mitosis in preimplantation mouse embryos. 1993 Reprod. Fertil. Dev. pmid:8272531
Jørgensen L et al. Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. 1993 Scand. J. Clin. Lab. Invest. pmid:8272758
Raff GW et al. Procoagulant property of platelet activating factor (PAF). 1993 Agents Actions pmid:8273543
Meats JE et al. Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. 1993 Agents Actions pmid:8273553
Thomas TK et al. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. 1993 Agents Actions pmid:8273566
Glaser KB et al. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). 1993 Agents Actions pmid:8273577
Chen ZN [Recent progress in the study of anti-PAF (platelet activating factor) constituents of medicinal herbs]. 1993 Zhongguo Zhong Yao Za Zhi pmid:8274205
Chau LY and Hu CY Platelet-activating factor receptor-mediated calcium influx in NG 108-15 cells. 1993 Chin J Physiol pmid:8275798
Montero A et al. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. 1993 Eur. J. Pharmacol. pmid:8276075
DeJoy SQ et al. Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis. 1994 J. Infect. Dis. pmid:8277176
Zhou W et al. Lipid mediator production in acute and chronic pancreatitis in the rat. 1994 J. Surg. Res. pmid:8277767
Denizot Y et al. [Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders]. 1993 Presse Med pmid:8278326
Huber W et al. Leukotriene B4 and C4 production in isolated rat gastric mucosal cells. 1993 Am. J. Physiol. pmid:8279553
Thompson WA et al. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. 1994 Arch Surg pmid:8279943
Turner JS et al. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. 1994 Biochem. J. pmid:8280096
Parent JL and Stankova J Transforming growth factor-beta up-regulates the gene expression of the human platelet-activating factor receptor in monocytic and B cell lines. 1993 Biochem. Biophys. Res. Commun. pmid:8280163
Tanaka T et al. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. 1994 Biochim. Biophys. Acta pmid:8280771
O'Flaherty JT et al. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. 1994 Biochim. Biophys. Acta pmid:8280772
Maziere C et al. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells. 1994 Biochim. Biophys. Acta pmid:8280775
Rodriguez-Roisin R et al. Platelet-activating factor causes ventilation-perfusion mismatch in humans. 1994 J. Clin. Invest. pmid:8282786
Tordai A et al. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine. 1994 J. Immunol. pmid:8283038
Gerard NP and Gerard C Receptor-dependent internalization of platelet-activating factor. 1994 J. Immunol. pmid:8283052
Zeng GQ et al. Effects of dauricine and tetrandrine on [3H] WEB 2086 specific binding to bovine anterior cerebral arterial smooth muscle cells in vitro. 1993 Yao Xue Xue Bao pmid:8285049
Gupta JB et al. Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209. 1994 Angiology pmid:8285381
Chupin VV et al. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine]. 1993 Bioorg. Khim. pmid:8285924
Chen BN et al. Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart. 1993 Cardiovasc. Res. pmid:8287433
Leoncini G et al. S-D-lactoylglutathione accumulation in activated human platelets. 1993 Int. J. Biochem. pmid:8288025
Parks JE and Hough SR Platelet-activating factor acetylhydrolase activity in bovine seminal plasma. 1993 Sep-Oct J. Androl. pmid:8288488
Sugatani J et al. Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation. 1993 J. Immunol. Methods pmid:8288878
Chang SW Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. 1994 J. Lab. Clin. Med. pmid:8288963
Pi F et al. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. 1994 Transplantation pmid:8291097
Bell M et al. Effect of cryoprotective additives and cryopreservation protocol on sperm membrane lipid peroxidation and recovery of motile human sperm. 1993 Nov-Dec J. Androl. pmid:8294232
Honda Z et al. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. 1994 J. Biol. Chem. pmid:8294489
Hodgkin EE et al. A Monte Carlo pharmacophore generation procedure: application to the human PAF receptor. 1993 J. Comput. Aided Mol. Des. pmid:8294944
Shinozaki K et al. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood. 1994 Life Sci. pmid:8295490
Sjogren R et al. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. 1994 Gastroenterology pmid:8299898
Caplan MS et al. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. 1994 Gastroenterology pmid:8299901
David S et al. Adherence of human monocytes to haemodialysis membranes. 1993 Nephrol. Dial. Transplant. pmid:8302460
Saeed SA et al. Rhazimine from Rhazya stricta: a dual inhibitor of arachidonic acid metabolism and platelet activating factor-induced platelet aggregation. 1993 Planta Med. pmid:8302958
Kosar-Hashemi B et al. Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition. 1993 Adv. Exp. Med. Biol. pmid:8304231
Northover AM and Northover BJ Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. 1993 Agents Actions pmid:8304240
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Jambou D et al. [Mediators of the vascular endothelium as markers of myocardial ischemia and reperfusion]. 1993 Arch Mal Coeur Vaiss pmid:8304814
Nishihira J et al. A role for oxygen radicals in rat monocytic leukemia cell differentiation under stimulation with platelet-activating factor. 1994 Biochim. Biophys. Acta pmid:8305501
Thorne JR and Broadley KJ Adenosine-induced bronchoconstriction in conscious hyperresponsive and sensitized guinea pigs. 1994 Am. J. Respir. Crit. Care Med. pmid:8306036
Filep JG and Földes-Filep E Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. 1993 Br. J. Pharmacol. pmid:8306074
Yamanaka S et al. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. 1993 Br. J. Pharmacol. pmid:8306093
Graham RM et al. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. 1994 Crit. Care Med. pmid:8306677
Denizot Y and Chaussade S Platelet activating factor and Crohn's disease. 1994 Gut pmid:8307440
Sun X et al. Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor. 1994 Gut pmid:8307472
Denizot Y and Chaussade S Tumor necrosis factor and platelet activating factor in stool during salmonellosis. 1994 Gut pmid:8307492